Putnam is pleased to announce the promotion of Benjamin Diop to Partner
“Benjamin is the rare talent that brings a deep technical background, a sharp strategic perspective, and a true partnership attitude to all of his engagements. His commitment to his client’s success is second to none. He has helped his clients navigate some of the most complex and fast-evolving markets in the life sciences industry and in doing so has helped drive the outstanding growth of our firm,” said Matt Riordan, Partner at Putnam Associates. “Everyone here at Putnam knows Benjamin is never without a smile and today we are all smiling as we announce his promotion to Partner. We look forward to his future success with the firm.”
Benjamin serves a range of life-science companies developing market opportunity assessments, global pricing and market access, therapeutic area, franchise, and product growth strategy, detailed forecasting, and market modeling. Benjamin has particular experience leading projects in oncology where he has mainly focused on both hematologic disorders (CML, MF, MM) and solid tumors (Pancreatic, Lung, Breast, and Glioblastoma), cardiovascular diseases, and infectious diseases. He also has broad experience leading cases involving launch preparation, launch planning, and the associated development of a value story and access landscape. Prior to joining Putnam, Benjamin was a Life Science specialist at L.E.K. Consulting with a focus on the healthcare, pharmaceuticals, and med tech industries. He received a Ph.D. from the joint Harvard – MIT Division of Health Sciences and Technology. Benjamin’s Ph.D. research focused on drug delivery in tumors. Benjamin also received a B.Eng in Chemical Engineering from Vanderbilt University.